SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:research.chalmers.se:534a8f74-874c-4d24-b532-b386d2ce1d6d"
 

Sökning: id:"swepub:oai:research.chalmers.se:534a8f74-874c-4d24-b532-b386d2ce1d6d" > Predicting response...

  • Johansson, Fredrik,1988Chalmers tekniska högskola,Chalmers University of Technology (författare)

Predicting response to tocilizumab monotherapy in rheumatoid arthritis: A real-world data analysis using machine learning

  • Artikel/kapitelEngelska2021

Förlag, utgivningsår, omfång ...

  • 2021-05-01
  • The Journal of Rheumatology,2021

Nummerbeteckningar

  • LIBRIS-ID:oai:research.chalmers.se:534a8f74-874c-4d24-b532-b386d2ce1d6d
  • https://research.chalmers.se/publication/526011URI
  • https://doi.org/10.3899/jrheum.201626DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:art swepub-publicationtype
  • Ämneskategori:ref swepub-contenttype

Anmärkningar

  • Objective. Tocilizumab (TCZ) has shown similar efficacy when used as monotherapy as in combination with other treatments for rheumatoid arthritis (RA) in randomized controlled trials (RCTs). We derived a remission prediction score for TCZ monotherapy (TCZm) using RCT data and performed an external validation of the prediction score using real-world data (RWD). Methods. We identified patients in the Corrona RA registry who used TCZm (n = 452), and matched the design and patients from 4 RCTs used in previous work (n = 853). Patients were followed to determine remission status at 24 weeks. We compared the performance of remission prediction models in RWD, first based on variables determined in our prior work in RCTs, and then using an extended variable set, comparing logistic regression and random forest models. We included patients on other biologic disease-modifying antirheumatic drug monotherapies (bDMARDm) to improve prediction. Results. The fraction of patients observed reaching remission on TCZm by their follow-up visit was 12% (n = 53) in RWD vs 15% (n = 127) in RCTs. Discrimination was good in RWD for the risk score developed in RCTs, with area under the receiver-operating characteristic curve (AUROC) of 0.69 (95% CI 0.62-0.75). Fitting the same logistic regression model to all bDMARDm patients in the RWD improved the AUROC on held-out TCZm patients to 0.72 (95% CI 0.63-0.81). Extending the variable set and adding regularization further increased it to 0.76 (95% CI 0.67-0.84). Conclusion. The remission prediction scores, derived in RCTs, discriminated patients in RWD about as well as in RCTs. Discrimination was further improved by retraining models on RWD.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Collins, JamieBrigham and Women's Hospital (författare)
  • Yau, VincentGenentech Inc. (författare)
  • Guan, HongshuBrigham and Women's Hospital (författare)
  • Kim, Seoyoung C.Brigham and Women's Hospital (författare)
  • Losina, ElenaBrigham and Women's Hospital (författare)
  • Sontag, D.Massachusetts Institute of Technology (MIT) (författare)
  • Stratton, JacklynBrigham and Women's Hospital (författare)
  • Trinh, HuongGenentech Inc. (författare)
  • Greenberg, JeffreyNew York University (författare)
  • Solomon, Daniel H.Brigham and Women's Hospital (författare)
  • Chalmers tekniska högskolaBrigham and Women's Hospital (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Journal of Rheumatology: The Journal of Rheumatology48:9, s. 1364-13701499-27520315-162X

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy